EIF2AK4 and head and neck squamous cell carcinoma: The role of GCN2 in other cancers has also been investigated; for example, tumor xenograft studies of head and neck squamous cell carcinoma (HNSCC), or fibrosarcoma (HT1080) cell lines with GCN2 deletions prevented tumor growth and survival [17,24].